Traders sold shares of Stryker Corporation (NYSE:SYK) on strength during trading on Tuesday. $32.09 million flowed into the stock on the tick-up and $72.39 million flowed out of the stock on the tick-down, for a money net flow of $40.30 million out of the stock. Of all stocks tracked, Stryker Corporation had the 0th highest net out-flow for the day. Stryker Corporation traded up $0.52 for the day and closed at $141.61

A number of research analysts have commented on the company. Cowen and Company reaffirmed a “buy” rating and set a $160.00 target price (up previously from $150.00) on shares of Stryker Corporation in a report on Sunday, July 30th. Zacks Investment Research downgraded Stryker Corporation from a “buy” rating to a “hold” rating in a report on Thursday, August 17th. BidaskClub raised Stryker Corporation from a “hold” rating to a “buy” rating in a report on Thursday, August 17th. Oppenheimer Holdings, Inc. set a $148.00 target price on Stryker Corporation and gave the stock a “hold” rating in a report on Friday, July 28th. Finally, Stifel Nicolaus increased their target price on Stryker Corporation from $151.00 to $158.00 and gave the stock a “buy” rating in a report on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, nine have given a hold rating and twelve have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average target price of $145.73.

The firm has a market cap of $53.03 billion, a PE ratio of 31.642 and a beta of 0.81. The company’s 50 day moving average is $144.32 and its 200-day moving average is $138.04.

Stryker Corporation (NYSE:SYK) last released its quarterly earnings data on Thursday, July 27th. The medical technology company reported $1.53 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.02. The company had revenue of $3.01 billion for the quarter, compared to the consensus estimate of $2.98 billion. Stryker Corporation had a return on equity of 24.26% and a net margin of 14.22%. The company’s quarterly revenue was up 6.1% on a year-over-year basis. During the same period in the previous year, the business earned $1.39 earnings per share. On average, equities analysts anticipate that Stryker Corporation will post $6.46 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 31st. Shareholders of record on Friday, September 29th will be issued a dividend of $0.425 per share. This represents a $1.70 dividend on an annualized basis and a yield of 1.20%. The ex-dividend date of this dividend is Thursday, September 28th. Stryker Corporation’s payout ratio is 37.95%.

In other news, insider Lonny J. Carpenter sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, August 4th. The stock was sold at an average price of $146.36, for a total value of $731,800.00. Following the transaction, the insider now directly owns 88,207 shares of the company’s stock, valued at approximately $12,909,976.52. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider David Floyd sold 19,305 shares of the business’s stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $144.56, for a total value of $2,790,730.80. The disclosure for this sale can be found here. Insiders sold a total of 25,429 shares of company stock worth $3,686,927 over the last three months. 7.40% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in SYK. Everett Harris & Co. CA boosted its holdings in shares of Stryker Corporation by 95.5% in the 1st quarter. Everett Harris & Co. CA now owns 3,285 shares of the medical technology company’s stock worth $432,000 after acquiring an additional 1,605 shares in the last quarter. Russell Investments Group Ltd. boosted its holdings in shares of Stryker Corporation by 4.2% in the 1st quarter. Russell Investments Group Ltd. now owns 666,831 shares of the medical technology company’s stock worth $87,810,000 after acquiring an additional 26,874 shares in the last quarter. IFP Advisors Inc boosted its holdings in shares of Stryker Corporation by 24.0% in the 1st quarter. IFP Advisors Inc now owns 10,169 shares of the medical technology company’s stock worth $1,339,000 after acquiring an additional 1,967 shares in the last quarter. Greenwich Wealth Management LLC acquired a new position in shares of Stryker Corporation in the 1st quarter worth approximately $214,000. Finally, iAB Financial Bank boosted its holdings in shares of Stryker Corporation by 1.4% in the 1st quarter. iAB Financial Bank now owns 35,104 shares of the medical technology company’s stock worth $4,621,000 after acquiring an additional 468 shares in the last quarter. 74.18% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Investors Sell Shares of Stryker Corporation (SYK) on Strength (SYK)” was originally reported by Daily Political and is owned by of Daily Political. If you are accessing this article on another publication, it was illegally copied and reposted in violation of U.S. and international trademark & copyright laws. The legal version of this article can be accessed at https://www.dailypolitical.com/2017/09/07/investors-sell-shares-of-stryker-corporation-syk-on-strength-syk-2.html.

Stryker Corporation Company Profile

Stryker Corporation is a medical technology company. The Company offers a range of medical technologies, including orthopedic, medical and surgical, and neurotechnology and spine products. The Company’s segments include Orthopaedics; MedSurg; Neurotechnology and Spine, and Corporate and Other. The Orthopaedics segment includes reconstructive (hip and knee) and trauma implant systems and other related products.